MannKind Corp. (MNKD)

[WHS]

1 Thank you for the information
2 Although the stock price is not good, but no accidents in health care (afrezza more than a year)
3 Although there is no money, but the customer is good
4 Sanofi's $ 150 million, a year and a half to afrezza test, it is worth it. mnkd little to lose
5afrezza The future is bright
6 I have more and more mnkd (cheaper, very satisfied)
7 and now than a year ago, the stock is so cheap, but without any change in fundamentals mnkd